Friday 6 November 2026 Export CDNA’s income statement to Excel — free account

CareDx, Inc.

CDNA Healthcare Diagnostics & Research

CareDx, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $379.8 million, up 13.8% from fiscal 2024.

Revenue: +39.3%
EPS: +1,133.3%
Free cash flow: −68.6%

Quarter to September 2026, against a year earlier

Operating cash flow growth 3 yrs

78.84 2.51 +3.29%

Follow CDNA

Alert me

Market cap: $4.0B
P/E: 30.9×
Fwd P/E: 36.2×
Dividend yield: —
F-score: 5/9
Altman Z: 4.14
Beneish M: −3.36
Dividend safety: n/a

Overview

CareDx, Inc. (CDNA) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, CareDx, Inc. (CDNA) trades at a P/B ratio of 8.6×. Over the past ten years it has ranged from 0.0× (March 2018) to 35.4× (September 2018); the current reading is higher than 76% of that period. That is above the Diagnostics & Research industry median of 3.4× and above the Healthcare sector median of 2.3×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/CDNA/pb-ratio" width="100%" height="360" style="border:0" loading="lazy" title="CareDx, Inc. P/B ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/CDNA/metrics/pb-ratio">CareDx, Inc. (CDNA) P/B ratio — stockrow.com</a></p>

Period	P/B ratio	Change
FY2025	3.3×	10.94%
FY2024	3.0×	21.54%
FY2023	2.5×	78.85%
FY2022	1.4×	(73.07%)
FY2021	5.1×	(57.95%)
FY2020	12.1×	32.05%
FY2019	9.2×	(1.67%)
FY2018	9.3×	—
FY2017	0.0×	—
FY2016	1.9×	(25.40%)

Period	P/B ratio	Change
Sep 2026	7.2×	110.26%
Jun 2026	3.4×	21.69%
Mar 2026	2.8×	(14.49%)
Dec 2025	3.3×	34.98%
43 more quarters	Free account

Against its own ten years

Low 0.0× High 35.4×

Ten-year median 3.0×

Current reading's percentile 73

Company	P/B ratio
VCYT Veracyte, Inc. compare	1.4×
GRAL GRAIL, Inc. compare	2.4×
NEO NeoGenomics, Inc. compare	2.7×
RDNT RadNet, Inc. compare	4.4×
SHC Sotera Health Company compare	6.2×
WGS GeneDx Holdings Corp. compare	7.9×
CDNA CareDx, Inc.	8.6×
BLLN BillionToOne, Inc. compare	9.9×
ADPT Adaptive Biotechnologies Corporation compare	23.5×
Diagnostics & Research industry median	3.4×
Healthcare sector median	2.3×
Market median	1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

CareDx, Inc. (CDNA) P/B ratio

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on CDNA

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on CDNA

Stockrow Weekly